Other large investors have bought and sold shares of the company.
Advertisement
Several other analysts have also weighed in on the company.
Imperva Inc. (NYSE:IMPV)’s stock had its “outperform” rating reiterated by analysts at Oppenheimer Holdings Inc.in a research note issued to investors on Tuesday. Following the sale, the insider now owns 1,304,521 shares in the company, valued at $44,562,437.36.
Following RBC Capital Markets’s latest price target of 49 on the business this highlights that the broker now believes there is an increase of 1.79% from Imperva Inc’s current share price of 48.14. However, the stock managed to close at $47.58, a loss of 1.16% for the day. Two investment analysts have rated the stock with a sell rating, five have assigned a hold rating and sixteen have issued a buy rating to the company. The stock was downgraded to Hold from Buy, wrote analysts at Deutsche Bank, in a note issued to clients on Tuesday July 12, 2016. Macquarie began coverage on Imperva in a research note on Friday. In an insider trading activity, The Securities and Exchange Commission has divulged that Schmid Terrence J., officer (Chief Financial Officer) of Imperva Inc, had unloaded 5,000 shares at an average price of $37.66 in a transaction dated on May 31, 2016. Pacific Crest reaffirmed a “buy” rating and set a $65.00 price objective on shares of Imperva in a report on Sunday, May 22nd.
Imperva (NYSE:IMPV) last released its earnings results on Thursday, May 5th. The firm lowered its rating on IMPV from Buy to Hold. For the prior quarter revenue for the company hit $72.71M, with earnings at $0.2/share.
Analysts are modeling a loss of 4 cents per share on revenue of $66.06 million. The stock now has a consensus rating of “Buy” and a consensus target price of $57.89. Penserra Capital Management LLC acquired a new stake in Imperva during the fourth quarter valued at about $35,711,000. During the same period in the previous year, the firm earned ($0.26) earnings per share. BlackRock Institutional Trust Company N.A. raised its stake in Imperva by 3.1% in the first quarter. Looking forward, analysts on average predict that earnings for the current quarter would come in between $-0.08 and $-0.02. Finally, OppenheimerFunds Inc. raised its stake in Imperva by 30.5% in the fourth quarter. Strs Ohio now owns 16,900 shares of the company’s stock valued at $1,069,000 after buying an additional 200 shares in the last quarter.
Advertisement
The Company’s SecureSphere offers database security solutions to secure sensitive data stored in databases, File Security solutions to protect sensitive files on file servers, storage devices, content repositories, and meet regulatory compliance mandates and Web Application Security solutions to protect web applications from cyber attacks. The Companys suite of cyber-security offerings enables organizations to discover data and application assets and vulnerabilities, to protect information.
